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ABSTRACT
The immunopathogenesis of toxoplasmosis during pregnancy is not completely understood. This
paper will try to discuss the most frequently asked questions about the immunopathogeny of con-
genital toxoplasmosis: differential virulence of Toxoplasma isolates, genetic susceptibility to infection,
facilitation of placental transfer, models of congenital toxoplasmosis, and transmission in seropos-
itive hosts. Most published data suggest a role of the genetic background of the host and of the
parasite. Models of congenital toxoplasmosis have been evaluated, but it appears that the conclusion
drawn would be barely appropriate to understand the pathogenesis in pregnant women. Infect. Dis.
Obstet. Gynecol. 5:121-127, 1997. (C) 1997 Wiley-Liss, Inc.
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oxoplasmosis is a parasitic infection caused by
the protozoan Toxop/asma gondii that, when
contracted by a pregnant woman, can pose a serious
risk to her unborn baby. Fortunately, a pregnant
woman can follow some simple precautions that
can reduce her risk of infection. A pregnant woman
who contracts toxoplasmosis for the first time dur-
ing pregnancy has about a 30 percent chance of
passing the infection on to her fetus. However, the
risk and severity of the baby’s infection depend
partly on the timing of the mother’s infection.
Studies suggest that, when mothers are infected in
the first trimester, 14 percent of fetuses become
infected, as compared to 29 percent in the second
trimester and 59 percent in the third, z Babies
whose mothers had toxoplasmosis in the first tri-
mester usually have the most severe infections. If
no screening program is carried out, most infected
babies appear normal at birth. However, most of
them will develop sight-threatening eye infections
months to years after birth. Some also will develop
hydrocephalus, mental retardation, learning dis-
abilities or seizures. Toxoplasmosis during preg-
nancy also can result in miscarriage or stillbirth.
Other infected babies have a severe Toxop/asma
infection that is evident at birth with severe eye
infections, hepatosplenomegaly, icterus and hydro-
cephalus.
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The parasite is most often picked up through
exposure to cat feces or by eating raw or under-
cooked meat that is contaminated with the para-
site. Cats often become infected when they eat an
infected rodent or bird. The parasite reproduces in
the cat’s intestine, and a form of the parasite (oo-
cysts) ends up in the cat’s litter box, sand or soil.
This form of the parasite becomes infectious
within days and is resistant to most disinfectants.
Under the right temperature and humidity condi-
tions, the parasite may live in soil for more than a
year. Infected cats usually appear healthy.
Toxoplasmosis is one of the most common in-
fections in the world as proven by the high preva-
lence of antibodies in the adult population, al-
though there are important geographic discrepan-
cies. Most cases of toxoplasmosis are undiagnosed.
Symptoms, if any, tend to resemble flu. Active in-
fection normally occurs only once in a lifetime. Al-
though the parasite remains in the body indefi-
nitely, it is generally harmless and inactive unless
the immune system is not functioning properly. If
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a woman develops immunity to the infection be-
fore pregnancy, there is rarely any danger of pass-
ing it on to her baby (see general information at
http://babynet.ddwi.com/tlc/pregnancy/toxoplas.
html).
If basic knowledge concerning the biology of
this parasite or the immune response in experimen-
tal animals is important, the knowledge on the
pathogenesis of congenital toxoplasmosis is rela-
tively scarce. This paper will try to discuss the most
frequently asked questions about the immunopa-
thogeny of toxoplasmosis in pregnancy.
ARE SOME ISOLATES OF TOXOPLASMA
GONDII MORE VIRULENT?
Toxop/asma gondii was discovered at the beginning
of the century in North Africa and is considered as
the only representative of the genus Toxoplasma.
Parasitic Stages
Three stages of the parasite can be found in in-
fected mammals: the sporozoite, the tachyzoite and
the bradyzoite. Sporozoites are liberated by the di-
gestion of infective oocysts (result of the sexual
multiplication of the parasite in the cat intestine)
and will penetrate through the intestinal epithe-
lium to infect host cells. The tachyzoite is a rapidly
intracellular dividing form responsible for the acute
phase of the disease and able to penetrate in prac-
tically all types of cells. The host immune response
will lead to the transformation of the tachyzoites in
bradyzoites. This conversion could depend on en-
vironmental triggers such as pH, temperature via
induction of heat-shock proteins, anti-mitochon-
drial drugs, nitric oxide and TNF-alpha.4 The
bradyzoite is a slowly dividing form giving cerebral
or muscular cysts and responsible for a life-long
immune stimulation of the infected host. Hosts can
be infected by these three parasitic stages: oocysts
by contact with contaminated cat feces, tachyzoites
by transplacental contamination, bradyzoites by in-
gestion of raw meat-containing cysts. The viru-
lence of these stages should be similar but anti-
genic differences have been described,s,6
Parasitic Strains
One of the characteristics of many Toxoplasma
strains is their variation in virulence. For example
the highly virulent RH strains will kill experimen-
tally infected mice in less than a week, whereas
most strains isolated from congenital cases of toxo-
plasmosis or animals will give a chronic disease in
mice characterised by the presence of cysts in the
brain. There is no correspondence between viru-
lence in humans and virulence in mice. Analysis of
different strains by isoenzymes allowed the de-
scription of at least five zymodemes. 7 Isolates
highly pathogenic for mice (e.g., RH strain) belong
to zymodeme or 5. Isolates giving a chronic in-
fection in mice belong to zymodeme 2 (e.g., Prug-
naud, 76K, Me49, Beverley), zymodeme 3 (e.g.,
C56) or zymodeme 4. Isolates from human congen-
ital toxoplasmosis belonged to the five groups.7’8
More recent data with restriction fragment length
polymorphism indicate that Toxoplasma gondii con-
sists of three clonal lineages, designated I, II and
III. Group I corresponds to zymodeme 1, group II
to zymodemes 2 and 4, group III to zymodeme 3.
More than 70% of human disease cases are associ-
ated with type II strains.9 The type II strain would
also be the most prevalent in food animals such as
pigs and sheep. Acute virulence in mice is strictly
observed in type I strains, indicating that a genetic
determinant(s) unique to this lineage controls
acute pathogenesis. 1,11
Strains and Congenital Infections
No link is proven between a particular type of
strain and transplacental passage. However, in an
experimental model in Fisher rats, Zenner et al. lz
using three different strains (RH, 76K & Prug-
niaud) obtained significant differences of congeni-
tal toxoplasmosis between the two strains RH and
Prugniaud and strain 76K. The rates of infected
fetuses were 58.2% for RH, 62.8% for Prugniaud
and 35.2% for 76k, respectively. However, though
having apparently different rates of placental trans-
mission, strains 76K and Prugniaud belong to the
same zymodeme. These different types of viru-
lence could be linked to different surface receptors
or antigens whose role in pathogenesis is not fully
elucidated.
ARE SOME INDIVIDUALS MORE SENSITIVE
TO INFECTION?
It is well proven that different mouse strains ex-
hibit different levels of resistance to Toxoplasma
gondii.
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Genetic Control
Genetics of survival after oral Toxoplasma gondii in-
fection were studied by using recombinant inbred
strains of mice derived from resistant A/J (A) and
susceptible C57BL/6J (B) progenitors, F1 progeny
of crosses between A/J and C57BL/6J mice, and
congenic mice (B10 background). Analysis of the
pattern of survival indicated that survival was regu-
lated by a minimum of five genes. One of these
genes appears to be linked to the H-2 complex. 13’14
BALB/c mice infected intraperitoneally will have
fewer brain cysts than C57/BL mice (15); B10 mice
(H-2b) are cyst susceptible and B10.A mice (H-2a)
are cyst resistant, 16 confirming that susceptibility to
Toxoplasma gondii and the number of brain cysts in
mice are affected by genes linked to the H-2 locus.
In a study by Deckert-Schluter et al., 17 the influ-
ence of genetic factors in congenic B 10 and BALB
mice of H-2q, H-2k, and H-2b haplotypes was ex-
amined following oral infection with a low-
virulence strain. Whereas B10 mice were highly
susceptible, BALB mice had a less severe and more
protracted disease. Within the two congenic
groups, the major histocompatibility complex hap-
lotype had a strong impact on the disease. The
H-2k haplotype was associated with early death in
B10 mice but with a favourable outcome in BALB
mice, whereas the reverse was observed for the
H-2q haplotype. These findings indicate that ge-
netically determined factors are critically involved
in determining the intracerebral immune response
and the course of murine toxoplasmosis, but sig-
nificant differences between B10 and BALB mice
point to a modulating role of additional genetic
loci. Moreover, this genetic control of resistance
against acute infection depends on the strain of
Toxoplasma gondii.
18 The use of transgenic mouse
models has shown that human MHC genes had a
role on the number of brain cysts. Introduction of
HLA-B27 into B10 mice made them more suscep-
tible to cyst formation. 14 Interestingly, recent pre-
liminary results have shown that in infants with
severe congenital toxoplasmosis the frequency of
HLA class II allele DQ3 was increased though the
frequency of this allele in the mother did not differ
from that in the normal population.4 In addition,
marked differences in infection patterns have been
observed between dizygotic twins compared to the
similar patterns between monozygotic twins. 14
Sex SusceptibiliW
Female mice were found to be more susceptible to
acute infection, as determined by higher mortality
levels, than male mice. Female mice surviving
chronic infections harboured more cysts in their
brains than did surviving males. Spleen cells from
male mice produced higher levels of interferon
(INF)-gamma in the early stages of infection than
those from female mice.9 Male severe combined
immunodeficiency (SCID) mice were also more re-
sistant than female mice to infection with Toxo-
plasma gondii producing interleukin (IL)-12 more
rapidly and exhibiting higher levels of INF-
gamma,z There is no data concerning differential
susceptibilities to toxoplasmic infections between
human males and females.
ARE THERE FACTORS FACILITATING
TRANSPLACENTAL TRANSMISSION
OF TOXOPLASMA?
A primary infection with Toxoplasma gondii will in-
duce in the infected host a humoral and cellular
immune response.
Factors Involved in the Immune Response
The acute phase of the disease is characterised in
humans and mammals by a significant increase of
specific IgA and IgM antibodies directed against
the main major antigenic component P30 or
SAG1.z This SAG1 has an important role in the
invasion of host cells: monoclonal antibodies di-
rected against SAG1 will block invasion,zz the
chronic stage being characterised by the presence
of specific IgG. However, these circulating anti-
bodies, witnesses of the infection, are useless to
control the disease. As with most intracellular para-
sites, this role should be set down to cellular im-
munity and particularly to T cells. INF-gamma has
a crucial role against this infection: mice treated by
anti-INF-gamma or deficient for INF-gamma gene
will die of toxoplasmosis,z3,z4 The first cells to be
activated are natural killer (NK) and monocytic
cells which will produce INF-gamma and IL-12.
IL-12 induces the lymphocyte population (CD4+
and CD8+) to a Thl phenotype inhibiting Toxo-
plasma growth. The Th2 derived cytokines will
have a counter-regulatory effect,zs
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Influence of Pregnancy on the
Immune Response
Some authors have recently shown that human pla-
centa was escaping the maternal immune system
by releasing immunosuppressive cytokines such as
IL-4, IL-6 and IL-10.z6 This pattern of cytokine
secretion, characteristic of a relative increase in
Th2-associated immunity and decreased Thl im-
munity, could facilitate the survival and/or the pas-
sage of the parasite through the placenta, but this
point remains unproven for Toxoplasma. Candolfi
et al. orally infected BALB/c mice and showed that
pregnant mice had a larger lung parasite load 7 days
post infection and a significantly higher number of
brain cysts 30 days post infection,z7 The different
patterns of cytokines described failed to explain
this increase susceptibility, though high titers of
the immunosuppressive IL-10 were observed.
Hohlfeld et al. reported in 1990z8 the different sub-
sets of T cells observed in infected pregnant
women and their fetuses. Women infected by
Toxoplasma during their pregnancy showed an in-
crease of CD8 suppressor T cells and a decrease of
CD4 helper T cells. These alterations were more
important when the fetus was infected, suggesting
that transmission could be enhanced by an im-
paired T cell immunity secondary to pregnancy.
Interestingly, children with congenital toxoplasmo-
sis have a specific immunological tolerance for
Toxoplasma gondii with a selective reduction of
INF-gamma production,zs
ARE ANIMAL MODELS USEFUL TO
UNDERSTAND PATHOGENESIS OF HUMAN
TOXOPLASMOSIS DURING PREGNANCY?
The human placenta structure (hemochorial) is
similar to the placental structure of mice, rats, rab-
bits and monkeys (but different from the placental
structure of dogs, cats, sheep, and pigs). Therefore,
a lot of information could have been obtained from
easy to handle experimental animals, but, curi-
ously, the number of papers describing models of
congenital toxoplasmosis are relatively few.
Rodent Models
Older studies with outbred mice showed that trans-
mission was possible through successive genera-
tions. However, studies conducted by Roberts et
al. is with BALC/c mice demonstrated that trans-
mission occurred only in mice infected for the first
time during pregnancy. In an experimental model
using orally infected Fisher rats, transmission to
fetuses was only possible in rats infected for the
first time. lz These results were obtained with two
different strains of Toxoplasma and with different
modes of infection (orally and intraperitoneally).
Primate Model
Schoondermark-Van de Ven described a very inter-
esting rhesus monkey model of Toxoplasma con-
genital infection. Transmission to the fetus was in-
vestigated after maternal infection at day 90 or day
130 of pregnancy. A parasitemia was induced and
lasted for about 10 days as proven by mouse inocu-
lation and nested polymerase chain reaction (PCR)
on blood samples. An overall transmission rate of
61% was found; this rate is similar to that found in
humans,z9 A lot of interesting results were obtained
on the efficacy of treatments usually prescribed in
humans. Spiramycin accumulated in the soft tis-
sues, especially in the liver and spleen, of both the
mother and the fetus and was concentrated in pla-
cental tissue and in amniotic fluid.3 In four mon-
keys that received treatment for about 7 weeks, the
parasite was not present at birth in the placenta nor
in amniotic fluid or neonatal organs.
31 Pyrimeth-
amine and sulfadiazine was administered to six
monkeys, in whose fetuses infection was diagnosed
antenatally. The parasite was no longer detectable
in the next consecutive amniotic fluid sample,
taken 10 to 13 days after treatment was started.
Furthermore, Toxoplasma gondii was not found in
the neonate at birth. The parasite was still present
at birth in three of four untreated fetuses that
served as controls.z Immune responses (beside cir-
culating antibodies) were not studied in these ex-
periments.
Absence of In Vitro Models
Important data could be obtained from in vitro
models similar to what was described for malaria.3
Cultivation ofhuman synctiotrophoblast with Toxo-
plasma would permit the study of molecules medi-
ating attachment and their expression in presence
of different cytokines and hormones. An up-
regulation of adhesion molecules has been de-
scribed in the pathogenesis of murine toxoplasmic
encephalitis.4
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CAN A SEROPOSITIVE HOST TRANSMIT
TOXOPLASMA TO THE FETUS?
This important point has been already discussed
previously in rodents where older data reported
that vertical transmission through successive gen-
erations was the normal situation in outbred
mice. is The dogma for humans (and ovids) is that
only infection for the first time during pregnancy
results in congenital infections. But this dogma
could be run down by recent observations. Des-
monts et al.3s reported five cases of congenital
toxoplasmosis consecutive to a maternal Toxo-
plasma infection that had preceded pregnancy. One
woman with a normal immune system had devel-
oped a well-documented lymph node toxoplasmo-
sis 2 months before conceiving. Four women had
chronic toxoplasmosis diagnosed in the course of an
immunosuppressive disease: Hodgkin’s disease in
one case, systemic lupus erythematosus in two
cases and pancytopenia in one case. Toxoplasmosis
had been recognised 3, 5 and 10 years respectively
before conception in three women, and at an un-
certain date in one woman. Three women had re-
ceived corticosteroids during pregnancy, and two
had undergone splenectomy. Among the six chil-
dren (two were twins), one presented with severe
fetal disease at birth, one developed lethal sys-
temic toxoplasmosis after birth, one showed hydro-
cephalus with therapeutically well-controlled cho-
rioretinitis, one had an isolated eye lesion and two
had asymptomatic infection. The parasite seems to
have been transmitted after the 20th week of preg-
nancy in all cases. Pons et al.36 and Vogel et al.37
reported a few years later two additional woman
with normal immune systems who developed toxo-
plasmosis 2 months before conceiving and who
transmitted the disease to their fetuses. Though
Marry et al.38 reported a case of severe fetal toxo-
plasmosis resulting of toxoplasmic reactivation in
an human immunodeficiency virus (HIV)-I sero-
positive woman, this phenomenon appears very
uncommon as proven by subsequent studies in co-
horts of HIV-positive pregnant women.39,4
Reinfection During Pregnancy
More disturbing is the case we have recently re-
ported.41 This case of congenital transmission was
revealed by macular chorioretinitis in a nine-
month-old child and confirmed by a retrospective
serological analysis of the mother’s sera. This
woman tested positive for anti-Toxoplasma antibod-
ies at 11 weeks of amenorrhoea (moderate titers of
IgG antibodies without IgM, thus reflecting an old
infection). No further toxoplasmic surveillance was
therefore carried out during pregnancy. At delivery,
clinical examination of the newborn was normal.
However, 9 months later, the child developed di-
vergent strabismus. Ophthalmologic examination
revealed a macular chorioretinitis scar, with loss of
right-sided vision. Congenital toxoplasmosis was
confirmed by the detection of IgM antibodies in
the child’s serum. As the mother took part in a
hematological survey during pregnancy, stored sera
were available for analysis. Reinfection during the
pregnancy was strongly suggested by the emer-
gence of IgM and IgA antibodies and a rise in IgG
titers between 11 and 28 W.A. The maternal rein-
fection was probably linked to oocysts, as her per-
sonal diary referred to contacts with kittens on
week 18 of amenorrhoea, and to a flu-like illness a
week later. There were no iatrogenic or apparent
pathological factors of immunodeficiency, or abnor-
malities in lymphocyte subsets. To our knowledge,
two other similar case have been reported.4z,4 Re-
infection of apparently immunocompetent women
during pregnancy is fortunately uncommon, but
raises the possibility that ingestion of Toxoplasma
cysts contained in meat does not protect against
reinfection by oocysts. This could be explained by
the antigenic differences between sporozoites and
tachyzoites described by Kasper and Wares but also
by strain differences. Recently Araujo et al. pub-
lished evidences that chronic infection in SW mice
with the ME49 Toxoplasma gondii strain did not
prevent acute disease or colonisation of the brain
after reinfection with cysts of a variant of the C56
strain resistant to atovaquone.
44
CONCLUSION
The immunopathogenesis of toxoplasmosis during
pregnancy is not completely understood. However,
most published data suggest a role of the genetic
background of the host and of the parasite. Models
of congenital toxoplasmosis have been evaluated,
but it appears that the conclusion drawn would be
barely appropriate to understand the pathogenesis
in pregnant women. A lot of trials (not reviewed
here) have been performed to evaluate Toxoplasma
proteins which could be used as vaccines. Most
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trials were performed with the P30 protein (SAG1)
but had limited efficiency. In France, a national
survey has recently shown a 54.3% prevalence of
Toxoplasma antibodies in pregnant women, and the
incidence of seroconversion in nonimmune women
at the beginning of pregnancy was of 1.5%.45 In
France, a national prevention program was set up
in the late seventies requiring compulsory serology
before wedding and during the first trimester of
pregnancy. If the serology is negative at the begin-
ning of pregnancy, hygienic recommendations will
be prescribed and the woman’s serum should be
checked every 3-4 weeks in order to detect a toxo-
plasmic infection very early. In case of a serocon-
version, the fetus will be assessed regularly by
echography and a prenatal diagnosis will be per-
formed at 20-22 weeks of pregnancy. This French
national prevention program could prevent 700 to
2650 cases per year of congenital toxoplasmosis
with an annual cost of $30 to 60 million.
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